Home > Publications database > ATACing single cells with phages. > print

001     178603
005     20240229143550.0
024 7 _ |a 10.1016/j.molcel.2021.12.028
|2 doi
024 7 _ |a pmid:35063091
|2 pmid
024 7 _ |a 1097-2765
|2 ISSN
024 7 _ |a 1097-4164
|2 ISSN
024 7 _ |a altmetric:121284828
|2 altmetric
037 _ _ |a DKFZ-2022-00152
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Maschmeyer, Patrick
|b 0
245 _ _ |a ATACing single cells with phages.
260 _ _ |a New York, NY
|c 2022
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1646916714_14581
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #LA:A010#
520 _ _ |a Fiskin et al. (2021) developed a 'multi-omics' approach that integrates phage-displayed single-domain antibodies ('nanobodies') with the assay for transposase-accessible chromatin (PHAGE-ATAC) to simultaneously determine protein expression, chromatin accessibility, and mitochondrial DNA mutations (for clonal tracing) in single cells.
536 _ _ |a 311 - Zellbiologie und Tumorbiologie (POF4-311)
|0 G:(DE-HGF)POF4-311
|c POF4-311
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
700 1 _ |a Haas, Simon
|0 P:(DE-He78)a5ec4e2fef99022a37a6b07c2fdd6325
|b 1
|e Last author
|u dkfz
773 _ _ |a 10.1016/j.molcel.2021.12.028
|g Vol. 82, no. 2, p. 234 - 236
|0 PERI:(DE-600)2001948-8
|n 2
|p 234 - 236
|t Molecular cell
|v 82
|y 2022
|x 1097-2765
909 C O |p VDB
|o oai:inrepo02.dkfz.de:178603
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)a5ec4e2fef99022a37a6b07c2fdd6325
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-311
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Zellbiologie und Tumorbiologie
|x 0
914 1 _ |y 2022
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-01-28
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-17
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b MOL CELL : 2021
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-17
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-17
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b MOL CELL : 2021
|d 2022-11-17
920 2 _ |0 I:(DE-He78)A010-20160331
|k A010
|l A010 Stammzellen und Krebs
|x 0
920 1 _ |0 I:(DE-He78)A010-20160331
|k A010
|l A010 Stammzellen und Krebs
|x 0
920 1 _ |0 I:(DE-He78)V960-20160331
|k V960
|l V960 HI-Stem
|x 1
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A010-20160331
980 _ _ |a I:(DE-He78)V960-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21